Recommendations to promote equity, diversity and inclusion in decentralized clinical trials.

HOME
>
論文・技術情報
>
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials.

Recommendations to promote equity, diversity and inclusion in decentralized clinical trials.

アブストラクト	Decentralized clinical trials involving the use of digital tools to facilitate remote research are gaining momentum. Rapid advancements in digital technologies have supported the adoption of these trials. These innovations facilitate virtual interactions between clinical trial teams and participants by making it easier to collect, transfer and store electronic data. While some studies have demonstrated the potential for these approaches to reduce barriers to clinical trial participation, they are associated with several challenges that may create or worsen existing health inequalities and limit the generalizability of trial results. Here we review the potential for digitally enabled and decentralized clinical trials to enhance clinical trial participation in an equitable manner. We describe the key barriers individuals from underserved groups may face, and provide recommendations to promote equity, diversity and inclusion.
ジャーナル名	Nature medicine
Pubmed追加日	2024/10/30
投稿者	Aiyegbusi, Olalekan Lee; Cruz Rivera, Samantha; Kamudoni, Paul; Anderson, Nicola; Collis, Philip; Denniston, Alastair K; Harding, Rosie; Hughes, Sarah E; Khunti, Kamlesh; Kotecha, Dipak; Krumholz, Harlan; Liu, Xiaoxuan; McMullan, Christel; Molony-Oates, Barbara; Monteiro, Joao; Myles, Puja; Rantell, Khadija Rerhou; Soltys, Katherine; Verdi, Ravinder; Wilson, Roger; Calvert, Melanie J
組織名	Centre for Patient Reported Outcomes Research, Institute of Applied Health;Research, College of Medical and Dental Sciences, University of Birmingham,;Birmingham, UK. o.l.aiyegbusi@bham.ac.uk.;National Institute for Health and Care Research Birmingham Biomedical Research;Centre, University of Birmingham, Birmingham, UK. o.l.aiyegbusi@bham.ac.uk.;National Institute for Health and Care Research Applied Research Collaboration;West Midlands, University of Birmingham, Birmingham, UK.;o.l.aiyegbusi@bham.ac.uk.;National Institute for Health and Care Research Blood and Transplant Research;Unit in Precision Transplant and Cellular Therapeutics, University of Birmingham,;Birmingham Health Partners Centre for Regulatory Science and Innovation,;University of Birmingham, Birmingham, UK. o.l.aiyegbusi@bham.ac.uk.;Birmingham, UK.;University of Birmingham, Birmingham, UK.;Merck, Darmstadt, Germany.;Centre, University of Birmingham, Birmingham, UK.;University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.;Birmingham Law School, University of Birmingham, Birmingham, UK.;Centre for Ethnic Health Research, National Institute for Health and Care;Research Applied Research Collaboration East Midlands, University of Leicester,;Leicester, UK.;Diabetes Research Centre, University of Leicester, Leicester, UK.;Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.;West Midlands NHS Secure Data Environment, University Hospitals Birmingham NHS;Foundation Trust, Birmingham, UK.;Yale School of Medicine, Yale University, New Haven, CT, USA.;Health Research Authority, London, UK.;Nature Medicine, New York, NY, USA.;Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory;Agency, London, UK.;Medicines and Healthcare products Regulatory Agency, London, UK.;Health Canada, Ottawa, Ontario, Canada.;Cancer Research Advocacy Forum, London, UK.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/39472759/